# LEVOTHYROXINE SODIUM
> **ANDA207588** · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS TEVA · Approved 2022-05-10
## Drug
- **FDA Application Number:** ANDA207588
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LEVOTHYROXINE SODIUM
- **Generic name:** LEVOTHYROXINE SODIUM
- **Active ingredients:** LEVOTHYROXINE SODIUM
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** WATSON LABS TEVA
- **Manufacturer:** Teva Pharmaceuticals, Inc.
- **First approval:** 2022-05-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207588)
---
*MORVS · CC0 1.0*